Arlington Capital Partners is seeking to sell Everest Clinical Research, a Toronto-based contract research organization, Axios Pro has learned from multiple sources. Arlington recently interviewed sell-side advisors, and the business will be marketed on about $45 million of EBITDA.
Read the full article: Arlington Preps Everest Clinical Research for Sale //
Source: https://www.axios.com/pro/health-tech-deals/2026/03/23/arlington-everest-clinical-research-sale